Novo Nordisk lowering prices for weight loss, diabetes drugs for cash customers
PositiveU.S News

- Novo Nordisk has decided to lower prices for its weight loss and diabetes drugs, specifically Wegovy and Ozempic, to $199 per month for self
- The price reduction is significant for Novo Nordisk as it seeks to enhance accessibility to its medications, potentially increasing its customer base among those who pay out
- Despite the price cut, healthcare professionals remain concerned about the overall affordability of these medications for uninsured patients. The ongoing debate about drug pricing and access to essential medications continues to highlight the challenges faced by many individuals in managing their health conditions effectively.
— via World Pulse Now AI Editorial System







